Trump Administration Proposes Redefining Title X Family Planning Program with…
The Department of Health and Human Services seeks to reshape Title X, shifting away from contraception access toward fertility and reproductive health conditions amid…
Archive 
Dr. Erica Schwartz selected as White House’s preferred candidate to lead CDC
Dr. Erica Schwartz, a former deputy Surgeon General and U.S. Coast Guard rear admiral, has emerged as the White House’s top choice to head…
New Service Offers to Fight Health Insurance Claim Denials for Patients
A company called Sheer Health is helping patients appeal denied medical claims amid widespread coverage delays and denials
Patient Advocacy Company Helps Navigate Insurance Denials for Critical Surgeries
A growing number of patients are turning to firms that handle insurance claim denials, highlighting ongoing challenges in health care approvals
New Medicaid Work Requirements Expected to Strain State Staffing and Access to Benefits
States face growing challenges to staff Medicaid offices and process eligibility amid new federal work rules set to take effect in 2027
Abbvie and Genentech join TrumpRx to offer discounted prescription drugs
Abbvie and Genentech become the 10th and 11th pharmaceutical companies to provide discounted medications through the White House’s TrumpRx prescription program
3.1 Million Bottles of Eye Drops Sold at Walgreens, CVS Recalled Over Sterility Concerns
The FDA has recalled over 3 million bottles of eye drops from multiple brands sold at major U.S. retailers due to potential sterility issues
HHS Launches $144 Million Program to Study Microplastics’ Impact on Human Health
The Department of Health and Human Services introduces a national initiative to investigate how microplastics affect the human body, prioritizing vulnerable groups and developing…
New Weight Loss Drug Foundayo to Be Offered on Trump’s Drug Pricing Platform
The FDA-approved weight loss pill Foundayo will be sold on the Trump administration’s pharmaceutical price comparison site with coupons for uninsured Americans starting at…
FDA Approves Eli Lilly’s Newweight Loss Drug
The FDA has authorized Eli Lilly’s latest GLP-1 medication for weight loss, potentially expanding treatment options for obesity